NMTR - 9 Meters Biopharma - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

7.803M

Cash

6.939M

Avg Qtr Burn

-9.311M

Short % of Float

4.54%

Insider Ownership

1.66%

Institutional Own.

16.43%

Qtr Updated

03/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Larazotide Details COVID-19	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Vurolenatide (NM-002) (GLP-1 Agonist) Details Rare diseases, Bowel disorder	Phase 2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Larazotide Details Celiac disease, Autoimmune disease	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.